NLS Pharmaceutics Ltd. - Warrant (NLSPW)

Last Price0.0142

Change+0.0001 (0.71%)

NASDAQ · Last Trade: Jul 26th, 4:38 AM EDT

NLS Pharmaceutics CEO Highlights Progress And Plans For Advancing Rare CNS Disorder Therapies In Shareholder Letterbenzinga.com

NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) recently released a comprehensive shareholder letter by its CEO, Alex Zwyer, detailing recent achievements and ongoing endeavors.

Via Benzinga · August 28, 2023